Plain-English translation of NCT06557876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests whether pulse field ablation, a newer catheter ablation technique, better preserves your heart's normal function compared to cryoablation, a standard ablation method used to treat paroxysmal atrial fibrillation. Both approaches work to eliminate the irregular heart rhythms by isolating the veins that trigger them, but researchers want to see if the newer technique causes less damage to your heart muscle.
Standard ablation procedures like cryoablation effectively treat atrial fibrillation, but they can affect how well your heart muscle works. This trial exists to find out whether this newer ablation technology preserves your heart's function better while still stopping the irregular rhythms.
You likely qualify if…
You likely don't qualify if…
You will undergo one of the two ablation procedures (either pulse field ablation or cryoablation) to treat your atrial fibrillation. You will have two special heart imaging scans (MRI with contrast dye) before and after your procedure to measure how your heart function is affected. You will also complete quality of life questionnaires to share how you are feeling. Your total participation lasts about 4 months.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
France